News in brief: InhaleRx; Hemp Pet; Neurotech International; Cann Group by Martin Lane November 19, 2024November 19, 2024 InhaleRx has received Human Research Ethics Committee (HREC) approval to start a Phase II clinical trial […]
InhaleRx secures up to $38.5m in funding for clinical trial program by Martin Lane October 18, 2024October 18, 2024
Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne by Martin Lane and Steve Jones September 2, 2024September 3, 2024
Company news: ECS Botanics; Althea; InhaleRx; Neurotech International by Martin Lane and Steve Jones July 10, 2024July 11, 2024
Company news: Zelira Therapeutics; Ecofibre; Cann Group; InhaleRx; Argent Biopharma; Melodiol Global Health; Wellnex Life by Steve Jones July 4, 2024November 25, 2024
Company news: Medibis; Althea; Elixinol; InhaleRx; Ecofibre; Aura Therapeutics; AusCann by Martin Lane April 4, 2024July 16, 2024
Company news: Folium Dispensary; Montu; Vantage Hemp Co; Cann Global; InhaleRx by Martin Lane March 4, 2024November 25, 2024
Company news: Cann Global; Cann Group; InhaleRx; AusCann; Wellnex Life; Neurotech; MGC Pharma; Stenocare by Martin Lane December 4, 2023April 30, 2024
Cannvalate named in US fraud lawsuit as InhaleRx distances itself from legal stoush by Steve Jones November 16, 2023April 5, 2024
